Awareness of Counselor Trainees on Clients’ Social Barriers

Author(s):  
Arie Greenleaf ◽  
Joseph Williams ◽  
David Duys
2009 ◽  
Author(s):  
Alex L. Pieterse ◽  
Noah M. Collins ◽  
Arthur Ritmeester ◽  
Ke Fang ◽  
Simon Chung

2011 ◽  
Author(s):  
Lonnie E. Duncan ◽  
Joseph Morris ◽  
Sheryl Kelly ◽  
Brian P. Littleton ◽  
Branson Boykin

2003 ◽  
Vol 93 (3) ◽  
pp. 753-754
Author(s):  
Deborah Barlieb ◽  
Brian Wlazelek ◽  
Donald J. Scandell

88 counselor-trainees were given information about a potential client using either a problem-focused or strength-focused pre-intake form Based on the information provided, counselor-trainees rated the client on the perceived severity of client's problem, difficulty of treatment, attractiveness of case, anticipated duration of treatment, and usefulness of the pre-intake information. This pilot project suggested that the type of information provided to trainees influenced their perceptions of the case, in particular, affording a more positive view of the client.


Author(s):  
Kimberly K. Scarsi ◽  
Susan Swindells

As with other chronic conditions, adherence to daily medications remains a challenge for many individuals living with HIV due to structural, behavioral, and social barriers. Unfortunately, high levels of adherence to antiretroviral therapy are required to maintain virologic suppression. Alternative approaches are being explored to decrease the burden of daily pill administration, including long-acting injectable, oral, and implantable products. Phase 3 data support the efficacy of nanoformulated injectable cabotegravir and rilpivirine for HIV treatment in patients with undetectable viremia, but we have yet to learn how this strategy may benefit those with medication adherence challenges. Despite this, the affected community and HIV providers are very interested in exploring the role of long-acting therapies to address some types of barriers to medication adherence. This review summarizes available information about the potential for long-acting therapy to improve adherence for some patients and outlines associated opportunities and challenges with the implementation of long-acting therapy for the treatment and prevention of HIV.


1974 ◽  
Vol 3 (4) ◽  
pp. 19-23
Author(s):  
Anthony Broskowski ◽  
Frank Baker

Sign in / Sign up

Export Citation Format

Share Document